Skylabs and Kakao Healthcare Sign Business Agreement to Establish Chronic Disease Management System

Hwang Hee, CEO of Kakao Healthcare (left), and Lee Byung-hwan, CEO of Skylabs, are posing for a commemorative photo after signing a business agreement.

[Asia Economy Reporter Lee Gwanju] Healthcare startup Skylabs announced on the 4th that it has signed a Memorandum of Understanding (MOU) with Kakao Healthcare to establish a mobile chronic disease management system.

The two companies plan to collaborate on developing a mobile service aimed at managing chronic diseases domestically and internationally by collecting and analyzing Patient-Generated Health Data (PGHD) voluntarily produced by patients through Skylabs' wearable monitoring medical devices.

Skylabs' ‘CART-I plus,’ used for PGHD collection, is a wearable medical device for chronic disease management that can be worn like a ring and provides 24-hour monitoring without any user operation. Using an optical sensor (PPG), it continuously measures oxygen saturation, heart rate, and irregular pulse waves, and it can also measure electrocardiograms (ECG) using an ECG sensor. Data measured through CART-I plus is automatically transmitted to the cloud, and the collected data is processed into medically meaningful data through AI technology developed in-house by Skylabs.

Lee Byunghwan, CEO of Skylabs, said, “Through collaboration with Kakao Healthcare, we expect to provide a broader range of digital healthcare services to more people,” adding, “We plan to actively utilize the resources of both companies to create excellent services that contribute to improving the quality of life through daily health management for chronic disease patients.”

Hwang Hee, CEO of Kakao Healthcare, stated, “Skylabs is a leading smart healthcare company providing remote monitoring through a ring-shaped medical device and platform that ensures convenience in daily life,” and added, “We are very excited about the future as we have partnered with Skylabs, which has already been recognized for its innovation and product quality overseas.”

Skylabs is a startup that provides solutions to manage diseases based on biometric signals collected in daily life through wearable medical devices and remote platforms. It has obtained domestic medical device approval and the European medical device certification CE-MDD (Medical Devices Directive).

This content was produced with the assistance of AI translation services.